Beta‐blockers for hypertension
17 results
1 - 17
Hypertension treatment effective even after age 80- Lowering blood pressure does not decrease the risk of T2DM in persons with hypertension; ACEIs/ARBs do
- Beta-blockers and tricyclic antidepressants are more commonly associated with orthostatic hypotension
- Meta-analysis: BP drugs equally effective in young and old
- Bedtime instead of morning ingestion of hypertension meds = significantly more reduction in cardiovascular disease risk
- Treatment for mild hypertension is ineffective
- Guideline for the management of heart failure: early prevention for patients at risk, quadruple therapy for those with symptoms
- JNC 8 report on prevention/evaluation/treatment of hypertension
- Beta-blockers associated with improved morbidity/mortality in COPD patients
- BP lowering by any means is beneficial in most
- Antihypertensive therapy beneficial for patients with BP < 140/90 and history of CVD
- In hypertensive CKD, intensive BP control only helpful for higher risk patients
- COVID-19 research briefs: Antihypertensive use not associated with an increased risk of SARS-CoV-2 infection
- ACE = ARB for secondary CV prevention; combination worse (ONTARGET)
- ACC/AHA guidelines for atrial fibrillation